Uncategorized
Dollar General Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts
Latest Ratings for DG Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Feb 2022 Wells Fargo Upgrades Equal-Weight Overweight Jan 2022 Morgan Stanley Downgrades Overweight Equal-Weight View More Analyst Ratings for DG View the Latest Analyst Ratings read more
Boeing 787 Prices Could Jump By $40M In Worst-Case Scenario Amid Trump Tariffs, Warns AerCap Chief
AerCap CEO Aengus Kelly has raised concerns about the potential impact of tariffs on the pricing of Boeing Co. (NYSE: BA) aircraft. He warns that the prices could surge by as much as $40 million in a worst-case scenario. read more
Elon Musk’s Tesla Set For Lowest Quarterly Deliveries Since 2022, JPMorgan Predicts: ‘Brand Has Lost So Much Value So Quickly’
JPMorgan analysts forecast Tesla Inc. (NASDAQ: TSLA) to experience its weakest quarter for car deliveries since 2022. read more
Trump Wants No Tax For Americans Making Less Than $150,000 A Year, Says Howard Lutnick: ‘That’s What I’m Working For’
Trump Wants No Tax For Anybody Making Less Than $150,000 a year, Says Howard Lutnick. ‘That’s What I’m Working For’ read more
Marjorie Taylor Greene Demands FBI Probe Into ‘Wave Of Organized Attacks’ On Tesla —Questions Possible Democrat-NGO Ties
Rep. Marjorie Taylor Greene (R-Ga.) and fellow House Subcommittee on Delivering on Government Efficiency members have called for a federal investigation into what they describe as “organized attacks” targeting Tesla Inc. and CEO Elon Musk, questioning potential connections to Democrat-leaning organizations. read more
Mark Cuban Hints That This One Mistake Has Killed Too Many Shark Tank Deals: ‘Thought They Were Profitable And They Weren’t’
Mark Cuban warned that many small business owners on Shark Tank mistakenly believe they’re profitable, only to unravel during due diligence — a common oversight he says continues to kill deals and highlights a widespread failure to understand key financial metrics. read more
Palantir’s $4 Million ARPC Estimate ‘Flawed,’ Says ‘Pharma Bro’ Martin Shkreli, But ‘I Wouldn’t Bet Against Them’
Martin Shkreli, the controversial former hedge fund manager known as “Pharma Bro,” questioned but ultimately defended Palantir Technologies Inc.’s growth projections on Wednesday, calling analysis of the company’s $4 million average revenue per customer “flawed.” read more